LPCN (STOCKS)
Lipocine Inc.
$2.353800
+0.153800 (+6.99%)
Prev close: $2.200000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Mahesh V. Patel
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $17.45M
- Employees
- 16
- P/E (TTM)
- -1.35
- P/B (TTM)
- 0.94
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
5
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.42 | $-0.62 | +0.2022 | +32.50% |
|
Sep 2025 (Q3)
|
$-0.59 | $-0.55 | -0.0392 | -7.12% |
|
Jun 2025 (Q2)
|
$-0.41 | $-0.41 | -0.0020 | -0.49% |
|
Mar 2025 (Q1)
|
$-0.35 | $-0.36 | +0.0070 | +1.96% |
Financial Statements
| Revenues | $1.98M |
| Benefits Costs and Expenses | $11.60M |
| Costs And Expenses | $11.60M |
| Nonoperating Income/Loss | $744.07K |
| Operating Expenses | $12.35M |
| Depreciation and Amortization | $60.78K |
| Research and Development | $8.58M |
| Other Operating Expenses | $3.70M |
| Operating Income/Loss | -$10.37M |
| Income/Loss From Continuing Operations After Tax | -$9.63M |
| Income/Loss From Continuing Operations Before Tax | -$9.63M |
| Income Tax Expense/Benefit | $200.00 |
| Net Income/Loss | -$9.63M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$9.63M |
| Net Income/Loss Available To Common Stockholders, Basic | -$9.63M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Average Shares | 5,448,871 |
| Diluted Average Shares | 5,708,238 |
| Assets | $17.01M |
| Current Assets | $16.88M |
| Cash | $14.90M |
| Other Current Assets | $1.98M |
| Noncurrent Assets | $128.05K |
| Fixed Assets | $104.29K |
| Other Non-current Assets | $23.75K |
| Liabilities | $2.53M |
| Current Liabilities | $2.53M |
| Accounts Payable | $971.82K |
| Other Current Liabilities | $1.56M |
| Noncurrent Liabilities | $0.00 |
| Equity | $14.48M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $14.48M |
| Liabilities And Equity | $17.01M |
| Net Cash Flow From Operating Activities | -$9.76M |
| Net Cash Flow From Operating Activities, Continuing | -$9.76M |
| Net Cash Flow From Investing Activities | $5.89M |
| Net Cash Flow From Investing Activities, Continuing | $5.89M |
| Net Cash Flow From Financing Activities | $2.87M |
| Net Cash Flow From Financing Activities, Continuing | $2.87M |
| Net Cash Flow | -$1.00M |
| Net Cash Flow, Continuing | -$1.00M |
| Comprehensive Income/Loss | -$9.63M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$9.63M |
| Other Comprehensive Income/Loss | -$9.63M |